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Abstract
Purpose. Antimicrobial resistance is a significant threat to public health. Diagnostic uncertainty is 
a key driver of antimicrobial prescribing. We sought to determine whether locally relevant, real-
time syndromic or microbiological infection epidemiology can improve prescribing by reducing 
diagnostic uncertainty.
Methods. Eligible studies investigated effects on primary care prescribing for common infections 
in Organisation For Economic Co-Operation And Development countries. We searched Medline, 
Embase, Cumulative index to nursing and allied health literature, Web of Science, grey literature 
sources, thesis databases and trial registries.
Results. We identified 9548 reports, of which 17 were eligible, reporting 12 studies, of which 3 
reported relevant outcomes. The first (observational) showed antibacterial prescribing for upper 
respiratory infections reduced from 26.4% to 8.6% (P = 0.01). The second (observational) showed 
antibacterial prescribing reduced during influenza pandemic compared with seasonal influenza 
periods [odds ratio (OR) 0.72 (95% CI, 0.68 to 0.77), P < 0.001], while antiviral prescribing increased 
[OR 6.43 (95% CI, 5.02 to 8.25), P  <  0.001]. The likelihood of prescribing also decreased as the 
number of infection cases a physician saw increased in the previous week [OR 0.57 (95% CI, 0.51 
to 0.63), P < 0.001 for ≥12 versus ≤1 patient). The third (randomized-controlled trial) showed an 
absolute reduction in antibacterial prescribing of 5.1% during a period of moderate influenza 
activity (P < 0.05). We did not find measures of diagnostic certainty, harms or costs.
Conclusion. There is promising evidence that epidemiological syndromic and microbiological 
data can reduce primary care antimicrobial prescribing. Future research should use randomized 
designs of behaviourally informed interventions, investigate costs and harms, and establish 
mechanisms of behaviour change.
PROSPERO registration. CRD42016038871.
Key words:  Antibacterial agents, general practice, infection, population surveillance, primary health care, public health 
surveillance.
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Introduction
  (i)  Antimicrobial resistance is a serious international health threat;
 (ii)  Diagnostic uncertainty is a key driver of antimicrobial prescrib-
ing for common infections in primary care;
(iii)  Our systematic review found two observational and one experi-
mental study, showing that real-time, locally relevant, syn-
dromic and microbiological epidemiological data can reduce 
antibacterial prescribing and 
(iv)  Future research should use randomized designs of behaviourally 
informed interventions, investigate costs and harms, and estab-
lish mechanisms of behaviour change.
Antimicrobial resistance (AMR) has been described as one of the 
greatest challenges to modern day public health (1). The over and mis-
use of antimicrobials are recognized as drivers of AMR, with high lev-
els of poorly targeted antimicrobials are prescribed in the community 
and 74% of all antibacterial prescribing occurring in general practice 
(2). The routine use of antibacterials in primary care has been shown 
to be directly linked to AMR (3,4), and the majority of patients pre-
senting to primary care with an uncomplicated respiratory tract infec-
tion in the UK still receive an antibacterial prescription (5).
Clinician uncertainty has been identified as a driver for prescrib-
ing antimicrobials in primary care and, therefore, a potential target 
for interventions looking to affect behaviour change of clinicians 
(6,7). Furthermore, consideration is required to determine how inter-
ventions can address this uncertainty, ensure continued safe man-
agement and appropriate prescribing of antimicrobials in situations 
where they are still required. Horwood et al. (8) suggest that addi-
tional support is needed for clinicians in their decision-making and 
interventions that seek to tackle this uncertainty in order to change 
clinician behaviour are more likely to affect a measurable change.
Improving antibacterial prescribing and reducing AMR are 
complex problems, requiring complex, multifaceted solutions. This 
systematic review evaluates one element of what could be a multi-
faceted approach to reduce clinician uncertainty, improve diagnostic 
accuracy and reduce antibacterial prescribing. We sought to deter-
mine whether locally relevant, real-time syndromic or microbiologi-
cal infection epidemiology could reduce diagnostic uncertainty and 
improve antibacterial prescribing. We also sought to describe the 
theoretical framework of sources contributing to surveillance sys-
tems and describe their breadth, purpose, data sources and intended 
recipients.
Methods
The review protocol was written following preferred reporting items 
for systematic reviews and meta-analyses (PRISMA) guidelines (9) 
and registered with PROSPERO (No.: CRD42016038871).
Search strategy
The search strategy (Supplementary Table S1) was designed to 
identify studies investigating the effect on primary care clinician 
management of common infections in Organisation for Economic 
Co-operation and Development (OECD) member countries (10) 
where the intervention includes dissemination of real-time, pop-
ulation-based data on locally relevant microbes or syndromic 
presentations.
Databases searched were Medline, Embase, Cumulative index to 
nursing and allied health literature (CINAHL) and Web of Science 
from database inception to April 2016. Medical subject headings 
(MeSH) terms and text word searches were combined to produce a 
comprehensive search strategy covering the following four key areas: 
‘common infection’, ‘primary care’, ‘population-based surveillance’ 
and ‘dissemination of information’. Grey literature sources includ-
ing WHO website and dissertation and thesis registries, includ-
ing Ethos and Proquest, were searched. Trial registries were also 
searched including US trial registry (clinicaltrials.gov), European 
Union (EU) clinical trial registry, International Standard Registered 
Clinical/Social Study Number (ISRCTN) register and meta-register 
of controlled trials and the health research authority (HRA) regis-
ter. Searches were conducted for records in any language. Full-text 
papers were subject to citation searches.
Study selection
Eligible studies were those investigating effects on primary care clin-
ician management of common (respiratory, gastrointestinal, urinary 
and skin) infections in OECD member countries where the interven-
tion included dissemination of real-time, population-based data on 
locally relevant microbes or syndromic presentations. Eligibility was 
assessed based on a hierarchy of factors: first, records were initially 
assessed for meeting the criteria of a common infection, and surveil-
lance systems for conditions such as human immunodeficiency virus 
(HIV), tuberculosis and malaria were excluded (see Supplementary 
Table S2 for examples of excluded conditions); second, they were 
checked for being conducted in an OECD member country; third, 
studies were assessed for being conducted in a primary care setting 
and finally that they disseminated information to primary care cli-
nicians, which was locally relevant (provision of data to clinicians 
more specific than national-level data) and in real time (provision of 
data to clinicians at least quarterly or more frequently).
One reviewer (IL) undertook initial title screening. At the next 
stage, the title and abstract screen was undertaken by one reviewer 
(IL) with a random 10% sample checked by a second reviewer 
(AB). A  kappa statistic of 0.69 demonstrated substantial agree-
ment between reviewers (11). Full-text records were assessed by two 
reviewers (IL and AB), and any disagreements resolved by discussion 
or, if needed, consultation with a third reviewer (ADH).
Data extraction and quality assessment
The following data were double extracted by two reviewers using a 
purpose-designed spreadsheet: author; year of publication; journal, 
study design; study country; OECD status; study setting; recruitment 
and details of participants; description of intervention; source and 
scope of surveillance data; mode and frequency of intervention dis-
semination; use of comparator group. Primary outcomes of interest 
to the review were antibacterial prescribing rates, secondary care 
referral rates and any harms attributable to the intervention. The 
secondary outcomes were types of antimicrobials or adherence to 
guidelines, consultation rates, costs and clinician diagnostic certainty.
We used the Cochrane Risk of Bias (ROB) tool 2.0 (12) to assess 
the quality of studies using a randomized controlled trial method-
ology, and we used the Risk Of Bias In Non-randomized Studies 
of Interventions (ROBINS-I) tool to assess study quality for non-
randomized intervention studies (13).
Data synthesis and analysis
Through familiarization with the literature during the screening pro-
cess, we planned to better understand and summarize the range of 
surveillance systems in use to be able to describe existing surveillance 
systems within the scope of this review. We conducted a narrative 
synthesis of the eligible studies and planned to conduct a meta-anal-
ysis if appropriate.
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Results
We identified 9548 records through database and additional searches 
(Fig. 1). Of these, 1693 were duplicates, 4018 were excluded on the 
basis of the title and 3799 were excluded following second title and 
abstract screen leaving 38 records to be retrieved in full text from the 
database and additional searches. A further 10 records were identified 
from reference lists, and an additional 2 records identified through 
contacting experts. We obtained these 50 records in full text; of which, 
33 did not meet our eligibility criteria. Of these 33 records, 5 were 
regarding conditions not considered common infections in primary 
care, 3 were not within OECD countries, 10 were not in a primary care 
setting, 11 did not disseminate any information and 4 were not locally 
relevant. Of the 17 records eligible for inclusion, several records report 
on the same study leaving 12 eligible studies for inclusion (14–25) 
with the remaining 5 records providing supporting material (26–30).
Of the 12 eligible studies, the principle records for each study 
included 10 publications in peer-reviewed journals (14–21,23,24) 
and two conferences proceedings (22,25).
Surveillance systems
Figure  2 shows the wide variety of surveillance system purposes 
(including AMR, surveillance, bioterrorism and food safety, as well 
as infection surveillance), data sources and intended recipients.
Study characteristics
Of the 12 eligible studies, one was a prospective cluster randomized 
controlled trial (25) and 11 were observational studies of a variety of 
designs, including cohort studies (14,16,19,22,23), programme descrip-
tions (15,18,20,21,24) and a pilot study (17). Eight of the studies took 
place in the USA (14–16,18,19,21,23,25), one in Canada (24), one in 
New Zealand (17), and two in Europe (Spain (20) and Norway (22)).
Study participants, interventions and outcomes
The level of detail provided on study participants varied and 
included general practitioners, primary care providers, family prac-
tice residents, urgent care clinics and community clinics. Four studies 
provided insufficient detail to clearly define participants (Table 1 and 
Supplementary Table S3) (15,18,20,21).
The interventions were wide-ranging and heterogeneous. Five 
studies disseminated syndromic data to clinicians (17,18,21,23–25), 
two disseminated microbiological data (14,19) and five disseminated 
a mixture of microbiological and syndromic data (15,16,20,22) 
(Table 1 and Supplementary Table S3). The majority of studies dis-
seminated infection surveillance information via websites, electronic 
databases and emails. One study disseminated information through 
biweekly faxes (14), one via a tool embedded in the electronic health 
record to be available on demand (25) and one study allowed users 
Figure 1. Systematic review flow chart (9). Infection surveillance in primary care. Years covered by review 1946–2016.
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to define how they wanted to receive the data from a range of 
options (18) (Table 1 and Supplementary Table S3). The majority of 
the studies provided information on a daily or weekly basis (Table 1 
and Supplementary Table S3). The studies included in this review 
presented the use of surveillance information for a range of different 
types of infections, including respiratory, gastrointestinal and skin 
infections (Table 1 and Supplementary Table S3). None of the studies 
described the use of a behavioural change model to design or imple-
ment their intervention.
A comparison group was described by three studies (14,23,25), 
and one additional study defined their planned comparison group 
(22) (Table 1 and Supplementary Table S3).
Three studies reported on antibacterial prescribing rates 
(14,23,25) (primary outcome), and two studies reported on antiviral 
prescribing rates (23,25) (secondary outcome; Table  2). The three 
studies reporting on outcomes of interest to this review all focussed 
on respiratory infections (14,23,25). No outcomes were reported 
on secondary care referral rates, harms, consultation rates, costs or 
diagnostic certainty (Supplementary Table S4).
Antibacterial prescribing rates (Table 2)
The three studies that reported on antibacterial prescribing rates var-
ied in the study design and included a cohort study with a historical 
control group (14), a retrospective cohort study (23) and a prospec-
tive cluster randomized controlled trial (25).
A reduction in antibacterial prescribing was seen following a 
3-year educational and surveillance programme delivered by Temte 
et al. (14) to family practice residents with prescribing falling from 
26.4% to 8.6% (P = 0.01) for upper respiratory infections. A reduc-
tion in antibacterial prescribing was reported by Hebert et al. (23) 
during a pandemic influenza period when compared with seasonal 
influenza periods: [odds ratio (OR) 0.72 (95% CI, 0.68 to 0.77), 
P < 0.001]. They also demonstrated that the likelihood of prescrib-
ing an antibacterial decreased as the number of febrile respiratory 
illness (FRI) cases that a physician had seen in the previous week 
increased—if 12+ patients were seen in the preceding week com-
pared with 0–1 patients, antibacterial prescribing reduced [OR 0.57 
(95% CI, 0.51 to 0.63), P < 0.001] (23). Shah et al. (25) reported 
a reduction in antibacterial prescribing following the introduction 
of an intervention providing clinicians with a syndromic heat map 
of influenza activity—they measured an absolute reduction in anti-
bacterial prescribing of 5.1% during a period of moderate influenza 
activity (P < 0.05).
Antiviral prescribing rates (Table 2)
Hebert et al. (23) described an increase in antiviral prescribing rates 
during a pandemic influenza period when compared with seasonal 
influenza periods: [OR 6.43 (95% CI, 5.02 to 8.25), P  <  0.001). 
They also demonstrated that the likelihood of prescribing an antivi-
ral agent increased as the number of FRI cases that a physician had 
seen in the previous week increased—if 12+ patients were seen in the 
preceding week compared with 0–1 patients, antiviral prescribing 
increased [OR 4.25 (95% CI, 3.42 to 5.28) P < 0.001) (23). Shah 
et al. (25) reported an absolute 1.6% increase in antiviral prescrip-
tions for influenza-like illness (ILI) visits during a high ILI activity 
(P-value not <0.05 but actual numerical value not reported).
Data synthesis and quality assessment
Further quantitative synthesis was not possible due to lack of numer-
ical outcomes reported and high levels of heterogeneity between the 
studies. Due to the challenges of implementing complex interven-
tions in a wide variety of clinical settings, there were numerous 
methodological challenges leaving studies open to relatively high 
levels of risk of bias (Tables 3 and 4).
Discussion
Summary of main findings
This review demonstrates the wide variety of surveillance systems 
and data sources that could support primary care antimicrobial 
Figure 2. Schema of surveillance systems by purpose, data source and intended recipient. Infection surveillance in primary care. Years covered by review 
1946–2016. OTC, over-the-counter; OOH, out-of-hours.
4 Family Practice, 2018, Vol. 00, No. 00
Downloaded from https://academic.oup.com/fampra/advance-article-abstract/doi/10.1093/fampra/cmy008/4911365
by University Library user
on 15 June 2018
Ta
b
le
 1
. 
S
tu
d
y 
ch
ar
ac
te
ri
st
ic
s 
o
f 
st
u
d
ie
s 
re
p
o
rt
in
g
 o
n
 p
ri
m
ar
y 
o
r 
se
co
n
d
ar
y 
o
u
tc
o
m
es
 o
f 
in
te
re
st
. I
n
fe
ct
io
n
 s
u
rv
ei
lla
n
ce
 in
 p
ri
m
ar
y 
ca
re
. Y
ea
rs
 c
ov
er
ed
 b
y 
re
vi
ew
 1
94
6–
20
16
A
ut
ho
r 
an
d 
ye
ar
 o
f 
pu
bl
ic
at
io
n
C
ou
nt
ry
D
es
ig
n
Pa
rt
ic
ip
an
ts
In
te
rv
en
ti
on
C
om
pa
ri
so
n
R
ec
ip
ie
nt
s 
of
 in
te
rv
en
ti
on
In
te
rv
en
ti
on
 d
et
ai
ls
M
ic
ro
bi
ol
og
ic
al
 (
M
) 
or
  
sy
nd
ro
m
ic
 (
S)
M
od
e 
an
d 
fr
eq
ue
nc
y
Te
m
te
 (
14
), 
19
99
U
SA
C
oh
or
t 
w
it
h 
 
hi
st
or
ic
al
 c
on
tr
ol
Fa
m
ily
 p
ra
ct
ic
e 
re
si
de
nt
s 
st
ar
ti
ng
 in
 1
99
2 
fo
r 
3 
ye
ar
s 
(n
 =
 1
4)
E
du
ca
ti
on
al
 a
nd
 s
ur
ve
il-
la
nc
e 
pr
og
ra
m
 d
el
iv
er
ed
 o
ve
r 
3 
ye
ar
s.
 S
um
m
ar
y 
re
po
rt
 o
f 
co
m
pi
le
d 
re
su
lt
s 
of
 v
ir
al
 c
ul
-
tu
re
s 
an
d 
ot
he
r 
cl
in
ic
al
 s
pe
ci
-
m
en
s 
se
nt
 t
o 
ei
gh
t 
di
ff
er
en
t 
su
rv
ei
lla
nc
e 
si
te
s.
 I
nf
or
m
at
io
n 
pr
ov
id
ed
 a
 r
ep
or
t 
sp
ec
ifi
c 
to
 
th
e 
si
te
 a
s 
w
el
l a
s 
re
gi
on
al
, 
st
at
e 
an
d 
na
ti
on
al
 t
re
nd
s
M
: R
es
pi
ra
to
ry
 v
ir
al
 c
ul
tu
re
 
re
su
lt
s 
(r
es
pi
ra
to
ry
).
B
iw
ee
kl
y 
fa
x
Fa
m
ily
 p
ra
ct
ic
e 
re
si
de
nt
s’
 
pr
e-
in
te
rv
en
ti
on
 (
n 
= 
8)
H
eb
er
t 
(2
3)
, 2
01
2
U
SA
R
et
ro
sp
ec
ti
ve
 c
oh
or
t
69
 p
hy
si
ci
an
s 
in
 2
6 
pr
ac
-
ti
ce
s.
 E
xp
os
ed
 g
ro
up
—
77
89
 p
at
ie
nt
 v
is
it
s 
du
ri
ng
 
th
e 
pa
nd
em
ic
 p
er
io
d 
ve
rs
us
 
20
 5
12
 v
is
it
s 
du
ri
ng
 t
he
 
no
n-
pa
nd
em
ic
 p
er
io
d
St
ud
y 
to
 e
xa
m
in
e 
th
e 
as
so
-
ci
at
io
n 
be
tw
ee
n 
co
nt
ex
tu
al
 
fa
ct
or
s 
an
d 
an
ti
m
ic
ro
bi
al
 
pr
es
cr
ib
in
g 
fo
r 
a 
FR
I. 
E
ff
ec
t 
of
 p
an
de
m
ic
 p
er
io
d—
he
av
y 
m
ed
ia
 c
ov
er
ag
e,
 p
ub
lic
 
an
xi
et
y,
 r
eg
ul
ar
 u
pd
at
es
 t
o 
ph
ys
ic
ia
ns
 o
n 
m
an
ag
em
en
t 
gu
id
el
in
es
, e
pi
de
m
io
lo
gi
ca
l 
da
ta
 a
nd
 v
ac
ci
ne
 in
fo
rm
at
io
n
S:
 F
R
I
A
le
rt
s 
an
d 
in
fo
rm
at
io
n 
re
ce
iv
ed
 d
ur
in
g 
a 
pa
n-
de
m
ic
 p
er
io
d
Se
as
on
al
 (
no
n-
pa
nd
em
ic
) 
pe
ri
od
 u
se
d 
as
 c
on
tr
ol
Sh
ah
 (
25
), 
20
14
 
(S
up
po
rt
in
g 
m
at
er
ia
l 
(2
9)
)
U
SA
Pr
os
pe
ct
iv
e 
cl
us
te
r 
R
C
T
27
 G
P 
pr
ac
ti
ce
s 
(c
lu
st
er
 
ra
nd
om
iz
ed
)
Sy
nd
ro
m
ic
 h
ea
t 
m
ap
 g
en
er
at
ed
 
fr
om
 d
at
a 
co
lle
ct
ed
 d
ai
ly
 f
ro
m
 
E
H
R
s 
to
 p
ro
vi
de
 G
Ps
 w
it
h 
a 
po
in
t 
of
 c
ar
e 
cl
in
ic
al
 d
ec
is
io
n 
su
pp
or
t 
to
ol
 a
va
ila
bl
e 
vi
a 
th
e 
E
H
R
 t
o 
G
Ps
 t
ha
t 
ge
ne
ra
te
s 
a 
sy
nd
ro
m
ic
 h
ea
t 
m
ap
 f
or
 I
L
I, 
pe
rt
us
si
s,
 G
A
S 
an
d 
pa
ed
ia
tr
ic
 
as
th
m
a
M
 a
nd
 S
: I
L
I, 
pe
rt
us
si
s,
 G
A
S 
an
d 
pa
ed
ia
tr
ic
 a
st
hm
a
O
n 
de
m
an
d 
vi
a 
th
e 
el
ec
tr
on
ic
 h
ea
lt
h 
re
co
rd
27
 G
P 
pr
ac
ti
ce
s 
(c
lu
st
er
 
ra
nd
om
iz
ed
)
G
A
S,
 G
ro
up
 A
 S
tr
ep
to
co
cc
us
; I
L
I, 
in
flu
en
za
-l
ik
e 
ill
ne
ss
; E
H
R
, e
le
ct
ro
ni
c 
he
al
th
 r
ec
or
ds
.
Epidemiological data improve clinician management and antimicrobial prescribing 5
Downloaded from https://academic.oup.com/fampra/advance-article-abstract/doi/10.1093/fampra/cmy008/4911365
by University Library user
on 15 June 2018
Ta
b
le
 2
. 
P
la
n
n
ed
 o
r 
re
p
o
rt
ed
 p
ri
m
ar
y 
o
r 
se
co
n
d
ar
y 
o
u
tc
o
m
es
 o
f 
in
te
re
st
 t
o
 t
h
e 
re
vi
ew
. I
n
fe
ct
io
n
 s
u
rv
ei
lla
n
ce
 in
 p
ri
m
ar
y 
ca
re
. Y
ea
rs
 c
ov
er
ed
 b
y 
re
vi
ew
 1
94
6–
20
16
St
ud
y
Pr
im
ar
y 
ou
tc
om
es
Se
co
nd
ar
y 
ou
tc
om
es
A
nt
ib
io
ti
c 
pr
es
cr
ib
in
g 
ra
te
s
SC
R
H
A
nt
im
ic
ro
bi
al
 t
yp
es
C
R
C
os
t
D
C
Te
m
te
 (
14
), 
19
99
A
 c
on
fid
en
ti
al
 r
ev
ie
w
 o
f 
ra
nd
om
ly
 s
el
ec
te
d 
m
ed
ic
al
 r
ec
or
ds
 t
o 
es
ti
m
at
e 
th
e 
ra
te
s 
of
 a
nt
ib
io
ti
c 
pr
es
cr
ib
in
g 
fo
r 
up
pe
r 
re
sp
ir
at
or
y 
in
fe
ct
io
n 
(U
R
I)
 a
nd
 b
ro
nc
hi
ti
s 
fo
r 
ea
ch
 r
es
id
en
t 
in
 1
99
6 
(n
 =
 1
4)
 a
nd
 1
99
2 
(n
 =
 8
). 
C
om
pa
ri
so
ns
 w
er
e 
m
ad
e 
be
tw
ee
n 
19
92
 a
nd
 1
99
6 
fo
r 
th
e 
m
ea
n 
ra
te
s 
of
 a
nt
ib
io
ti
c 
pr
es
cr
ib
in
g 
fo
r 
U
R
I 
an
d 
br
on
ch
it
is
 a
m
on
g 
th
e 
ch
ar
ts
 r
ev
ie
w
ed
 u
si
ng
 A
N
O
V
A
M
ea
n 
an
ti
bi
ot
ic
 p
re
sc
ri
bi
ng
 r
at
e 
(a
bs
ol
ut
e)
In
te
rv
en
ti
on
 g
ro
up
 (
n 
= 
14
)
C
on
tr
ol
 g
ro
up
 (
n 
= 
8)
U
R
I
8.
6%
26
.4
%
P
 =
 0
.0
1
B
ro
nc
hi
ti
s
80
.2
%
93
.1
%
N
S
C
om
po
si
te
28
.8
%
52
.3
%
P
 =
 0
.0
05
H
eb
er
t 
(2
3)
, 2
01
2
O
f 
th
e 
28
 3
01
 p
at
ie
nt
 e
nc
ou
nt
er
s 
fo
r 
FR
I 
w
it
h 
69
 p
hy
si
ci
an
s 
in
 2
6 
pr
ac
ti
ce
s,
 a
n 
an
ti
bi
ot
ic
 w
as
 
pr
es
cr
ib
ed
 in
 1
2 
79
5 
(4
5.
2%
) 
ca
se
s.
 P
re
sc
ri
bi
ng
 a
m
on
g 
ph
ys
ic
ia
ns
 v
ar
ie
d 
fr
om
 1
7.
9%
 t
o 
83
.7
%
. 
A
nt
ib
io
ti
cs
 w
er
e 
pr
es
cr
ib
ed
 in
 4
7.
5%
 (
97
41
 o
ut
 o
f 
20
 5
12
) 
of
 e
nc
ou
nt
er
s 
du
ri
ng
 t
he
 s
ea
so
na
l 
pe
ri
od
 a
nd
 3
9.
2%
 (
30
54
 o
f 
77
89
) 
du
ri
ng
 t
he
 p
an
de
m
ic
 p
er
io
d 
[O
R
 0
.7
2 
(9
5%
 C
I, 
0.
68
 t
o 
0.
77
), 
P
 <
 0
.0
01
]. 
T
he
 li
ke
lih
oo
d 
of
 p
re
sc
ri
bi
ng
 a
n 
an
ti
bi
ot
ic
 d
ec
re
as
ed
 a
s 
th
e 
nu
m
be
r 
of
 F
R
I 
ca
se
s 
th
at
 a
 p
hy
si
ci
an
 h
ad
 s
ee
n 
in
 t
he
 p
re
vi
ou
s 
w
ee
k 
in
cr
ea
se
d
A
nt
iv
ir
al
s 
pr
es
cr
ib
ed
 in
 5
.5
%
 c
as
es
 in
 
se
as
on
al
 p
er
io
ds
 a
nd
 1
2.
6%
 d
ur
in
g 
th
e 
pa
nd
em
ic
 p
er
io
d 
[O
R
 6
.4
3 
(9
5%
 C
I, 
5.
02
 t
o 
8.
25
), 
P
 <
 0
.0
01
]. 
If
 p
hy
si
ci
an
 
ha
d 
se
en
 >
12
 p
at
ie
nt
s 
w
it
h 
FR
I 
in
 t
he
 
pr
ec
ed
in
g 
w
ee
k,
 t
he
 o
dd
s 
of
 p
re
sc
ri
b-
in
g 
an
ti
vi
ra
ls
 w
er
e 
4.
25
 (
95
%
 C
I, 
3.
42
 
to
 5
.2
8)
 c
om
pa
re
d 
w
it
h 
se
ei
ng
 0
–1
 
pa
ti
en
ts
, P
 <
 0
.0
01
FR
I 
ca
se
s 
se
en
 in
 p
re
ce
d-
in
g 
w
ee
k
O
R
95
%
 C
on
fid
en
ce
 in
te
rv
al
2–
3
0.
93
0.
86
 t
o 
1.
01
4–
6
0.
84
0.
77
 t
o 
0.
91
7–
11
0.
71
0.
64
 t
o 
0.
78
12
+
0.
57
0.
51
 t
o 
0.
63
 (
P
 <
 0
.0
01
)
R
es
ul
ts
 c
om
pa
re
d 
w
it
h 
re
fe
re
nc
e 
ra
ng
e 
of
 0
–1
 p
at
ie
nt
s.
Sh
ah
 (
25
), 
20
14
 (
Su
pp
or
ti
ng
 
m
at
er
ia
l (
29
))
IL
I 
vi
si
ts
: 
T
he
 in
te
rv
en
ti
on
 a
rm
 d
id
 n
ot
 p
re
sc
ri
be
 f
ew
er
 a
nt
ib
io
ti
cs
 f
or
 I
L
I 
vi
si
ts
 t
ha
n 
th
e 
co
nt
ro
l a
rm
 o
ve
ra
ll 
(4
1.
1%
 v
er
su
s 
41
.3
%
 P
 =
 0
.9
0)
. 
H
ig
h 
IL
I 
ac
ti
vi
ty
—
in
te
rv
en
ti
on
 g
ro
up
 
ex
pe
ri
en
ce
d 
ab
so
lu
te
 2
.0
%
 r
ed
uc
ti
on
 in
 a
nt
ib
io
ti
c 
pr
es
cr
ip
ti
on
 f
or
 I
L
I 
vi
si
t 
(N
S)
. 
M
ed
iu
m
 I
L
I 
ac
ti
vi
ty
—
in
te
rv
en
ti
on
 g
ro
up
 e
xp
er
ie
nc
ed
 a
bs
ol
ut
e 
5.
1%
 r
ed
uc
ti
on
 in
 a
nt
ib
io
ti
c 
pr
es
cr
ip
ti
on
 f
or
 
IL
I 
vi
si
t 
(P
 <
0.
05
).
A
ll 
cl
in
ic
 v
is
it
s:
 
H
ig
h 
IL
I 
ac
ti
vi
ty
—
ab
so
lu
te
 1
.0
%
 r
ed
uc
ti
on
 in
 a
nt
ib
io
ti
c 
pr
es
cr
ip
ti
on
 (
P
 <
 0
.0
5)
. 
M
ed
iu
m
 I
L
I 
ac
ti
vi
ty
—
ab
so
lu
te
 1
.7
%
 r
ed
uc
ti
on
 in
 a
nt
ib
io
ti
c 
pr
es
cr
ip
-
ti
on
 (
P
 <
 0
.0
5)
A
nt
iv
ir
al
 p
re
sc
ri
bi
ng
H
ig
h 
IL
I 
ac
ti
vi
ty
—
 
in
te
rv
en
ti
on
 g
ro
up
 e
xp
er
ie
nc
ed
 a
b-
so
lu
te
 1
.6
%
 in
cr
ea
se
 in
 a
nt
iv
ir
al
 p
re
-
sc
ri
pt
io
n 
fo
r 
IL
I 
vi
si
t 
(N
S)
.M
ed
iu
m
 
IL
I 
ac
ti
vi
ty
—
in
te
rv
en
ti
on
 g
ro
up
 
ex
pe
ri
en
ce
d 
ab
so
lu
te
 0
.3
3%
 r
ed
uc
ti
on
 
in
 a
nt
iv
ir
al
 p
re
sc
ri
pt
io
n 
fo
r 
IL
I 
vi
si
t 
(P
 <
 0
.0
5)
.G
A
S 
sp
ec
ifi
c 
an
ti
bi
ot
ic
sH
ig
h 
G
A
S—
in
te
rv
en
ti
on
 g
ro
up
 a
bs
ol
ut
e 
3.
3%
 in
cr
ea
se
*.
M
ed
iu
m
 G
A
S—
in
te
rv
en
ti
on
 g
ro
up
 a
bs
ol
ut
e 
8.
4%
 
de
cr
ea
se
*.
L
ow
 G
A
S—
in
te
rv
en
ti
on
 
gr
ou
p 
ab
so
lu
te
 6
.7
%
 d
ec
re
as
e*
SC
R
, 
se
co
nd
ar
y 
ca
re
 r
ef
er
ra
l 
ra
te
s;
 H
, 
H
ar
m
s;
 C
R
, 
co
ns
ul
ta
ti
on
 r
at
es
 (
an
y 
m
ea
su
re
 o
f 
co
ns
ul
ta
ti
on
s)
; 
D
C
, 
di
ag
no
st
ic
 c
er
ta
in
ty
; 
FR
I, 
fe
br
ile
 r
es
pi
ra
to
ry
 i
lln
es
s;
 I
L
I, 
in
flu
en
za
-l
ik
e 
ill
ne
ss
; 
G
A
S,
 g
ro
up
 A
 S
tr
ep
to
co
cc
us
; 
U
R
I 
= 
up
pe
r 
re
sp
ir
at
or
y 
in
fe
ct
io
n;
 N
S,
 n
ot
 s
ig
ni
fic
an
t;
 g
re
y 
sh
ad
ed
, n
ot
 r
ep
or
te
d.
 *
R
es
ul
ts
 s
ig
ni
fic
an
t 
at
 P
 <
 0
.0
5 
va
lu
e.
 
6 Family Practice, 2018, Vol. 00, No. 00
Downloaded from https://academic.oup.com/fampra/advance-article-abstract/doi/10.1093/fampra/cmy008/4911365
by University Library user
on 15 June 2018
decision-making. We found few had been evaluated, but those that 
had shown promising, albeit methodologically weak, evidence that 
providing locally relevant, real-time epidemiological information 
improved antimicrobial prescribing in primary care.
Strengths and limitations
We conducted a novel, rigorous, comprehensive review for evidence 
to support one potential solution to an internationally recognized 
public health problem. The small number of included studies pre-
vented us from assessing the effects of publication bias (no studies 
were identified reporting an increase in antibacterial prescribing). 
Although the review set out to consider surveillance of any common 
infection relevant to primary care, the three studies included that 
reported on outcomes of interest to this review (14,23,25) focussed 
primarily on respiratory infections. It is important to recognize this 
limitation of the review and to take this into account when con-
sidering surveillance of non-respiratory infections. Even within 
respiratory infections, due to the low number of studies eligible for 
inclusion in the review, there are likely to be differences in applica-
tion of surveillance data for different types of respiratory infection. 
For example, for influenza, outcomes from the use of surveillance 
information as a clinical decision support tool may vary depending 
on whether the clinician is in a locality experiencing expected sea-
sonal activity of the virus, an epidemic or a pandemic.
Results in context with other studies
Most existing surveillance literature focuses on two elements: first, 
how to optimize accurate, timely data (microbiological, syndromic, 
absenteeism, over-the-counter sales) completion (31–33) and sec-
ond, distributing analyzed surveillance data to health departments 
and public health officials for outbreak detection and health service 
preparedness. As we have demonstrated, surveillance data are rarely 
targeted towards primary care clinicians with a view to changing 
clinical management. Qualitative research suggests that GPs are not 
Table 3. Quality assessment for non-randomized intervention studies using ROBINS-I tool (13). Infection surveillance in primary care. Years 
covered by review 1946–2016
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Table 4. Quality assessment for randomized intervention studies using Cochrane Risk Of Bias tool 2.0 (12). Infection surveillance in primary 
care. Years covered by review 1946–2016
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even aware of what surveillance data is publically available and do 
not currently access this type of information in their clinical practice 
to support their diagnostic reasoning (34).
Clinical and research implications
Even though only a small number of studies have demonstrated 
a trend towards reduced antibacterial prescribing with increased 
access to surveillance data for primary care clinicians, the evidence 
is not yet sufficiently mature to be used in routine practice, and sig-
nificant investment would be required to make existing data sources 
ready for intervention. That said, even small improvements in the 
primary care use of antibacterials could have significant implications 
for reducing AMR (3,4) and patient demand for primary care con-
sultations (35). To maximize the potential benefits of this type of 
intervention, future research needs to, first, establish what informa-
tion, and using which delivery method, would be most valued by 
clinicians and to, second, assess effects using adequately powered, 
randomized studies of interventions underpinned by robust behav-
iour change methods.
Conclusions
There is promising evidence that syndromic and microbiological epi-
demiological data can influence the use of antibacterials in primary 
care. Future research should use behaviourally informed interven-
tions, tested using prospective randomized designs; and establish the 
mechanisms of behaviour change.
Supplementary material
Supplementary data is available at Family Practice online.
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